-
Most Recent
Search Results
240 results for abb
AbbVie Inc Stock Dives on Lung Cancer Drug Results
AbbVie (ABBV) stock was falling hard today following results from a Phase 2 study of lung cancer drug Rovalpituzumab Tesirine.
ABBV Stock: Could AbbVie Inc’s Gamble on Stemcentrx Pay Off?
Stemcentrx’s acquisition does little to alleviate the risk of the potential decrease in sales once Humira loses patent protection.
Why Is AbbVie Stock Down Today?
AbbVie (ABBV) stock is slipping on Friday following the release of the biopharmaceutical company’s earnings report for Q1 2022.
3 Big Stock Charts for Tuesday: AbbVie Inc (ABBV), Gilead Sciences, Inc. (GILD) and Sprint Corp (S)
AbbVie (ABBV), Gilead (GILD) and Sprint (S) are all moving today after their respective earnings reports. All three have additional profit potential for those queued…
AbbVie Stock Has a $10 Upside Opportunity — Buy It Now
There is a $10 technical opportunity in ABBV stock just around the corner. Get on board AbbVie while the value is still reasonable.
Why Is Cerevel Therapeutics (CERE) Stock Up 12% Today?
Cerevel Therapeutics stock is climbing higher as CERE investors react to an $8.7 billion acquisition deal with AbbVie.
AbbVie (ABBV) a Strong Buy on Best-in-Class Quant Score
AbbVie Inc (NYSE:ABBV) is a constituent of the 350 company Biotechnology GICS industry group, which is a segment of the 782 company GICS Health Care…
Best-in-Class Quant Score Makes AbbVie (ABBV) a Strong Buy
AbbVie Inc (NYSE:ABBV) ranks in the top 10% of its industry group, Biotechnology, and in the top decile of sector group, Health Care, with a…
Why AbbVie Shares Are Sliding Today
AbbVie (ABBV) stock took a hit on Thursday following comments concerning biosimilars that were made over the past couple of days.
Why Is ImmunoGen (IMGN) Stock Up 81% Today?
ImmunoGen stock is taking off on news that AbbVie is acquiring all outstanding shares of IMGN in a $10.1 billion acquisition deal.
Gilead Stock: This Beatdown Was Way Overdone (GILD)
Gilead Sciences, Inc. (GILD) was driven down by news from AbbVie, but the market may have overreacted and turned Gilead stock into a value buy.
EOLS Stock: The Big News That Has Evolus Shares Skyrocketing Today
Evolus (EOLS) stock was on the rise Friday following news that it’s no longer dealing with lawsuits from AbbVie (ABBV) and Medytox.
3 Big Stock Charts: Netflix, Inc (NFLX), Intel Corporation (INTC) and Abbvie Inc (ABBV)
Intel’s (INTC) quiet rally has it prepared to accelerate to new multiyear highs, but AbbVie (ABBV) and Netflix (NFLX) could be headed lower.
Biggest Movers in Technology Stocks Now – NCR SYMC MXIM ABB
Technology stocks declined broadly on Wall Street today, with the sector seeing an overall decline of 0.5%. NYSE:NCR, NASDAQ:SYMC, NASDAQ:MXIM, NYSE:ABB, NASDAQ:UBNT, NYSE:EMC, NASDAQ:CA, NYSE:INFY,…
Greece Debt Weighs on Euro Zone ADR Investment in May (IRE, NBG, DB, ABB, DT, TOT)
The Greece debt crisis as well as budget woes in other so-called PIIGS nations in the euro zone — Portugal, Ireland, Italy, Greece and Spain…
Why Is Aldeyra Therapeutics (ALDX) Stock Up 40% Today?
Aldeyra Therapeutics stock is rising with heavy trading of ALDX shares after signing an exclusive option agreement with AbbVie.
Trade of the Day: ABBV Stock on the Verge of a Major Breakout
AbbVie Inc is challenging the recent double-top above $65.
3 Robotics Stocks That Could Be Multibaggers in the Making: March Edition
If you invest in these robotics stocks, you can be sure to see solid portfolio growth until at least 2030.
ABBV: A Great Way to Play Healthcare’s Comeback
AbbVie’s Humira is soon to be the world’s No. 1 best-selling drug. And its growth prospects couldn’t look better.
Hottest Technology Stocks Now – MR ABB PMCS ATML
Technology stocks fell on Wall Street on Thursday morning, down 0.5%.
6 – 10 of 240 results
